These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3020976)

  • 1. Conjugated estrogens and fibrocystic breast disease.
    Jick SS; Walker AM; Jick H
    Am J Epidemiol; 1986 Nov; 124(5):746-51. PubMed ID: 3020976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy and fibrocystic breast disease.
    Pastides H; Najjar MA; Kelsey JL
    Am J Prev Med; 1987; 3(5):282-6. PubMed ID: 2838061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen replacement therapy and benign breast disease.
    Trapido EJ; Brinton LA; Schairer C; Hoover R
    J Natl Cancer Inst; 1984 Nov; 73(5):1101-5. PubMed ID: 6092767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
    Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk after estrogen replacement therapy: results from the Toronto Breast Cancer Study.
    Palmer JR; Rosenberg L; Clarke EA; Miller DR; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1386-95; discussion 1396-401. PubMed ID: 1663701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.
    Lundström E; Wilczek B; von Palffy Z; Söderqvist G; von Schoultz B
    Climacteric; 2001 Mar; 4(1):42-8. PubMed ID: 11379377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-contraceptive exogenous estrogens and risk of breast cancer: a review.
    Thomas DB
    Breast Cancer Res Treat; 1982; 2(3):203-11. PubMed ID: 6295528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement therapy and fibrocystic breast disease in postmenopausal women.
    Berkowitz GS; Kelsey JL; Holford TR; LiVolsi VA; Merino MJ; Beck GJ; Ort S; O'Connor TZ; White C
    Am J Epidemiol; 1985 Feb; 121(2):238-45. PubMed ID: 4014118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
    Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Weiss NS; Larson EB; Rosendaal FR; Psaty BM
    JAMA; 2004 Oct; 292(13):1581-7. PubMed ID: 15467060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncontraceptive estrogen use and the risk of breast cancer.
    Kaufman DW; Miller DR; Rosenberg L; Helmrich SP; Stolley P; Schottenfeld D; Shapiro S
    JAMA; 1984 Jul; 252(1):63-7. PubMed ID: 6328053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical hyperplasia, proliferative fibrocystic change, and exogenous hormone use.
    Zera RT; Danielson D; Van Camp JM; Schmidt-Steinbrunn B; Hong J; McCoy M; Anderson WR; Linzie BM; Rodriguez JL
    Surgery; 2001 Oct; 130(4):732-7. PubMed ID: 11602905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of breast cancer after estrogen and estrogen-progestin replacement.
    Bergkvist L; Adami HO; Persson I; Hoover R; Schairer C
    N Engl J Med; 1989 Aug; 321(5):293-7. PubMed ID: 2546079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study.
    Troisi RJ; Speizer FE; Willett WC; Trichopoulos D; Rosner B
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1183-8. PubMed ID: 7551368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials.
    Mirkin S; Pinkerton JV; Kagan R; Thompson JR; Pan K; Pickar JH; Komm BS; Archer DF
    J Womens Health (Larchmt); 2016 May; 25(5):431-42. PubMed ID: 27058301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugated estrogen use and risk of endometrial cancer.
    Buring JE; Bain CJ; Ehrmann RL
    Am J Epidemiol; 1986 Sep; 124(3):434-41. PubMed ID: 3017100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium.
    Shapiro S; Kaufman DW; Slone D; Rosenberg L; Miettinen OS; Stolley PD; Rosenshein NB; Watring WG; Leavitt T; Knapp RC
    N Engl J Med; 1980 Aug; 303(9):485-9. PubMed ID: 6248785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
    Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy in postmenopausal women with benign fibrocystic mastopathy.
    Yenen MC; Dede M; Goktolga U; Kuçuk T; Pabuçcu R
    Climacteric; 2003 Jun; 6(2):146-50. PubMed ID: 12841885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugated estrogens and breast cancer risk in women.
    Hoover R; Glass A; Finkle WD; Azevedo D; Milne K
    J Natl Cancer Inst; 1981 Oct; 67(4):815-20. PubMed ID: 6268883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to first occurrence of breast pain and vaginal bleeding in phase 3 trials of CE/BZA.
    Pinkerton JV; Bushmakin AG; Bobula J; Lavenberg J; Komm BS; Abraham L
    Menopause; 2017 Dec; 24(12):1372-1377. PubMed ID: 28609389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.